financetom
Business
financetom
/
Business
/
Northwest Bancshares' Q4 Adjusted Earnings, Revenue Rise
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Northwest Bancshares' Q4 Adjusted Earnings, Revenue Rise
Jan 24, 2025 5:17 AM

07:49 AM EST, 01/24/2025 (MT Newswires) -- Northwest Bancshares ( NWBI ) reported Q4 adjusted earnings Friday of $0.27 per diluted share, up from $0.24 a year earlier.

Analysts polled by FactSet expected $0.25.

Revenue for the quarter ended Dec. 31, expressed as the sum of net interest income and total noninterest income, was $154.3 million, up from $135.5 million a year earlier.

Analysts surveyed by FactSet expected $141.5 million.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Squarespace Insider Sold Shares Worth $327,500, According to a Recent SEC Filing
Squarespace Insider Sold Shares Worth $327,500, According to a Recent SEC Filing
Mar 5, 2024
05:15 PM EST, 03/05/2024 (MT Newswires) -- Paul Gubbay, Chief Product Officer, on March 04, 2024, sold 10,000 shares in Squarespace ( SQSP ) for $327,500. Following the Form 4 filing with the SEC, Gubbay has control over a total of 46,186 shares of the company, with 46,186 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1496963/000156218024002294/xslF345X03/primarydocument.xml Price: 31.33, Change: -0.63, Percent Change:...
Bayer notches more wins in Roundup weedkiller cancer trials
Bayer notches more wins in Roundup weedkiller cancer trials
Mar 5, 2024
March 5 (Reuters) - Bayer on Tuesday said it won a trial in a lawsuit brought by a retired postal service worker in Pennsylvania who alleged he developed non-Hodgkins lymphoma from using the company's Roundup weedkiller. In addition to the jury verdict in the Philadelphia Court of Common Pleas, Bayer said a California farmer, who said he contracted the same...
Amicus Therapeutics Insider Sold Shares Worth $389,543, According to a Recent SEC Filing
Amicus Therapeutics Insider Sold Shares Worth $389,543, According to a Recent SEC Filing
Mar 5, 2024
05:15 PM EST, 03/05/2024 (MT Newswires) -- John F Crowley, Director, Executive Chairman, on March 01, 2024, sold 29,181 shares in Amicus Therapeutics ( FOLD ) for $389,543. Following the Form 4 filing with the SEC, Crowley has control over a total of 638,373 shares of the company, with 573,478 shares held directly and 64,895 controlled indirectly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1178879/000095017024026265/xslF345X03/ownership.xml...
Mongodb Insider Sold Shares Worth $3,466,497, According to a Recent SEC Filing
Mongodb Insider Sold Shares Worth $3,466,497, According to a Recent SEC Filing
Mar 5, 2024
05:15 PM EST, 03/05/2024 (MT Newswires) -- Dwight A Merriman, Director, on March 01, 2024, sold 8,000 shares in Mongodb ( MDB ) for $3,466,497. Following the Form 4 filing with the SEC, Merriman has control over a total of 1,780,680 shares of the company, with 1,160,784 shares held directly and 619,896 controlled indirectly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1441816/000144181624000042/xslF345X03/wk-form4_1709676677.xml Price: 411.49, Change:...
Copyright 2023-2026 - www.financetom.com All Rights Reserved